BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 1338321)

  • 1. Progress report on the anorectic effects of dexfenfluramine, fluoxetine and sertraline.
    Garattini S; Bizzi A; Caccia S; Mennini T
    Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 3():S43-50. PubMed ID: 1338321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on the pharmacology of serotoninergic appetite-suppressive drugs.
    Garattini S
    Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 4():S41-8. PubMed ID: 1338385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress report on the anorexia induced by drugs believed to mimic some of the effects of serotonin on the central nervous system.
    Garattini S; Bizzi A; Codegoni AM; Caccia S; Mennini T
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):160S-166S. PubMed ID: 1728827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two novel agents affecting eating through an action on monoaminergic systems.
    Roncucci R; Miranda GF; Verry M
    Int J Obes; 1984; 8 Suppl 1():103-17. PubMed ID: 6549508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of single and repeated anorectic doses of 5-hydroxytryptamine uptake inhibitors on indole levels in rat brain.
    Caccia S; Anelli M; Codegoni AM; Fracasso C; Garattini S
    Br J Pharmacol; 1993 Sep; 110(1):355-9. PubMed ID: 7693282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible involvement of endogenous opiates in the tolerance to the anorectic effect of fenfluramine.
    Groppetti A; Parenti M; Dellavedova L; Tirone F
    J Pharmacol Exp Ther; 1984 Feb; 228(2):446-53. PubMed ID: 6694120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. d-Fenfluramine and salbutamol: two drugs causing anorexia through different neurochemical mechanisms.
    Garattini S; Samanin R
    Int J Obes; 1984; 8 Suppl 1():151-7. PubMed ID: 6534892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of the anorectic agent, d-fenfluramine, and its primary metabolite, d-norfenfluramine, on intact human platelet serotonin uptake and efflux.
    Johnson GJ; Leis LA; Dunlop PC; Weir EK
    J Thromb Haemost; 2003 Dec; 1(12):2663-8. PubMed ID: 14675103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cocaine and selective monoamine uptake blockers (sertraline, nisoxetine, and GBR 12935) prevent the d-fenfluramine-induced head-twitch response in mice.
    Darmani NA
    Pharmacol Biochem Behav; 1998 May; 60(1):83-90. PubMed ID: 9610928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenfluramine and 5-hydroxytryptamine. Part 2: Involvement of brain 5-hydroxytryptamine in the anorectic activity of fenfluramine.
    Duhault J; Boulanger M; Voisin C; Malen C; Schmitt H
    Arzneimittelforschung; 1975 Nov; 25(11):1758-62. PubMed ID: 128366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of the anorectic actions of 5-HTP and fenfluramine.
    Fletcher PJ; Burton MJ
    Psychopharmacology (Berl); 1986; 89(2):216-20. PubMed ID: 3088639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of depletion of brain serotonin by repeated fenfluramine on neurochemical and anorectic effects of acute fenfluramine.
    Kleven MS; Schuster CR; Seiden LS
    J Pharmacol Exp Ther; 1988 Sep; 246(3):822-8. PubMed ID: 2458447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anorectic effect of fenfluramine isomers and metabolites: relationship between brain levels and in vitro potencies on serotonergic mechanisms.
    Mennini T; Garattini S; Caccia S
    Psychopharmacology (Berl); 1985; 85(1):111-4. PubMed ID: 2984709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological actions of drugs affecting serotonin and eating.
    Garattini S
    Obes Res; 1995 Nov; 3 Suppl 4():463S-470S. PubMed ID: 8697044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the effects on central 5-HT function of sibutramine hydrochloride and other weight-modifying agents.
    Heal DJ; Cheetham SC; Prow MR; Martin KF; Buckett WR
    Br J Pharmacol; 1998 Sep; 125(2):301-8. PubMed ID: 9786502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine increases the anorectic and long-term dopamine-depleting effects of phentermine.
    Callahan BT; Yuan J; Ricaurte GA
    Synapse; 2000 Dec; 38(4):471-6. PubMed ID: 11044894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sleep suppressant action of fenfluramine in rats. II. Evidence against the involvement of presynaptic serotonergic mechanism.
    Fornal C; Radulovacki M
    J Pharmacol Exp Ther; 1983 Jun; 225(3):675-81. PubMed ID: 6223135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability.
    Curzon G; Gibson EL; Oluyomi AO
    Trends Pharmacol Sci; 1997 Jan; 18(1):21-5. PubMed ID: 9114726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropharmacological effects of low and high doses of repeated oral dexfenfluramine in rats: a comparison with fluoxetine.
    Caccia S; Confalonieri S; Bergami A; Fracasso C; Anelli M; Garattini S
    Pharmacol Biochem Behav; 1997 Aug; 57(4):851-6. PubMed ID: 9259015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerance to the anorectic effect of dexfenfluramine in rats: role of serotonin, cholecystokinin, and neuropeptide Y.
    Rowland NE
    Physiol Behav; 1994 Feb; 55(2):201-7. PubMed ID: 8153156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.